Literature DB >> 29346535

Tricuspid regurgitation in acute heart failure: is there any incremental risk?

Diab Mutlak1, Jonathan Lessick1, Shehrban Khalil1, Sergey Yalonetsky1, Yoram Agmon1, Doron Aronson1.   

Abstract

Aim: Significant tricuspid regurgitation (TR) is common in heart failure (HF) and portends poor prognosis. We sought to determine whether the poor outcome results from the TR itself, or whether the TR is a surrogate marker of advanced left-sided myocardial or valvular heart disease. Methods and results: We studied 639 patients admitted for acute HF. The relationship between TR severity and the endpoint of readmission for HF or mortality was assessed after adjustment for multiple clinical and echocardiographic parameters. Higher TR grade was associated with higher congestion score and with other cardiac abnormalities including reduced left ventricular systolic function, moderate or severe mitral regurgitation, pulmonary hypertension (PH, defined as pulmonary artery systolic pressure ≥ 50 mmHg), and right ventricular dysfunction (all P < 0.001). Only 7% of patients with moderate or severe TR were free of other cardiac lesions. In adjusted models, moderate or severe TR was not associated with readmission for HF or mortality [hazard ratio (HR) 1.24, 95% confidence interval (95% CI) 0.97-1.57]. Patients with moderate/severe TR had similar risk for HF readmission or death compared with patients with trivial/mild TR when PH was not present (HR 1.17; 95% CI 0.78-1.75, P = 0.40) whereas the risk was higher in moderate/severe TR and PH (HR 1.78; 95% CI 1.34-2.36, P < 0.0001).
Conclusion: Patients presenting with symptomatic HF and significant TR have multiple coexisting cardiac abnormalities. TR provides no additive risk in the presence of normal or mildly elevated pulmonary pressures. However, it is associated with excess rehospitalizations and mortality in patients with PH.

Entities:  

Mesh:

Year:  2018        PMID: 29346535     DOI: 10.1093/ehjci/jex343

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

1.  The impact of tricuspid annular geometry on outcome after percutaneous edge-to-edge repair for severe tricuspid regurgitation.

Authors:  Sylvia Otto; Marija Velichkov; Ali Hamadanchi; P Christian Schulze; Sven Moebius-Winkler
Journal:  Cardiol J       Date:  2021-05-04       Impact factor: 2.737

Review 2.  Multi-Modality Imaging in the Evaluation and Treatment of Tricuspid Regurgitation.

Authors:  Samuel M Kim; Harsimran S Singh; Jillian Nati; Jonathan N Ginns
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-09

3.  Effect of Tricuspid Regurgitation on the Reported Quality of Life and Subsequent Outcomes in Patients With Atrial Fibrillation.

Authors:  Taishi Fujisawa; Takehiro Kimura; Nobuhiro Ikemura; Hiroshi Miyama; Yoshinori Katsumata; Ikuko Ueda; Kojiro Tanimoto; Hideaki Kanki; Keiichi Fukuda; Shun Kohsaka; Seiji Takatsuki
Journal:  J Am Heart Assoc       Date:  2022-04-06       Impact factor: 6.106

4.  The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction.

Authors:  Qing-Wen Ren; Xin-Li Li; Johnathan Fang; Yan Chen; Mei-Zhen Wu; Yu-Juan Yu; Shen-Gen Liao; Hung-Fat Tse; Kai-Hang Yiu
Journal:  ESC Heart Fail       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.